Clinical Study of Modified Sub-Hibernation Therapy Combined with Ganciclovir on Patients with Viral Encephalitis

Abstract

Viral encephalitis is an infectious disease of the nervous system caused by multiple viruses entering the brain. This disease is extremely harmful to the human body and has a high mortality rate. Modified sub-hibernation therapy and ganciclovir are the most commonly used treatments for viral encephalitis. The purpose of this article is to further explore the clinical effect of modified sub-hibernation therapy combined with ganciclovir on patients with viral encephalitis. Thirty viral encephalitis patients with severe illness and long-term illness were taken as the research object, and the patients were divided into three groups according to the condition and their own conditions, a control group, a ganciclovir treatment group and a modified sub-hibernation therapy combined ganciclovir observation group. The control group did not receive any treatment, the treatment group was treated with ganciclovir alone, and the observation group was treated with modified sub-hibernation therapy combined with ganciclovir. The diagnosis and prognosis of all patients were analyzed and studied. The results of the study showed that the treatment effective rate of the ganciclovir treatment group was 85.7%, and three patients relapsed after discharge from the hospital. The recurrence rate was 30%. The total effective rate of the modified sub-hibernation therapy combined with the ganciclovir observation group was 95.3%, only one person relapsed after discharge, the recurrence rate was 10%. It can be seen that the treatment of viral encephalitis with modified sub-hibernation therapy combined with ganciclovir has a very good therapeutic effect and the disease recurrence rate is low. It is the first choice for the treatment of viral encephalitis.